Fig. 4From: Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technologyCytocompatibility of nanovaccines. Quantification of LDH release-based cytotoxicity of the nanovaccines and control NP when compared to lysis buffer (unpaired t-test, ***p = 0.0007 with respect to lysis buffer, n.d.—non-detectable)Back to article page